Recently, it has been hypothesized that mitral leaflet remodelling may play a role in the pathophysiology of functional mitral regurgitation (FMR). We investigated the characteristics, determinants, and relation of mitral leaflet remodelling to FMR severity.
Introduction
Functional mitral regurgitation (FMR) affects 30% of patients with ischaemic heart disease or dilated cardiomyopathy and yields a dismal prognosis. 1 FMR is a complex problem, comprising dysfunction of a structurally normal mitral valve (MV) secondary to local or global left ventricular (LV) dysfunction with distorted LV geometry. 2 Recent data, however, have challenged the idea of the MV being only an 'innocent bystander' in FMR patients. In particular, it was shown that the MV in patients with end-stage heart failure exhibits extracellular matrix changes proportional to annular, atrial, and ventricular dimensions and function, including increased fibrosis (collagen), deoxyribonucleic acid (DNA and cellularity), and glycosaminoglycan extent. 3 These alterations coincided with increased leaflet thickness and length, reflecting structural leaflet remodelling. 3 Animal studies have also shown an up-regulation of the extracellular † P.D. and I.A.A. contributed equally to this manuscript and share first position.
matrix and mitral leaflet adaptation (increased area) as a compensatory response to LV dilatation or loading. 4, 5 More recent studies, using three-dimensional (3D) echocardiography which is ideally suited for detailed evaluation of MV anatomy and morphology, have shown the presence of MV leaflet remodelling in patients with LV dysfunction and have suggested that inadequate leaflet remodelling may be related to the presence of significant FMR. 6 -8 Data on characteristics, potential determinants, and the relationship of MV leaflet remodelling to FMR severity are scarce however. Therefore, the hypothesis of the present evaluation was to demonstrate whether inadequate leaflet remodelling on 3D echocardiography, expressed as the lack of leaflet coaptation relative to annular or LV changes, relates to the presence of significant FMR.
Methods Patients
Patients with FMR who underwent 3D transoesophageal echocardiography were included. FMR was defined as MR due to local or global LV dysfunction and/or remodelling in the absence of macroscopic morphological abnormalities of the MV. Clinical reasons for transoesophageal echocardiography in FMR patients comprised evaluation of severity of valvular dysfunction and specific underlying mechanism (n ¼ 35/54), screening for transcatheter MV repair eligibility (n ¼ 17/54), or diagnostic work-up before ventricular tachyarrhythmia ablation (n ¼ 2/54). A control group included patients with a macroscopically normal structural and functional MV who underwent clinically indicated 3D transoesophageal echocardiography to exclude cardiac embolism source (n ¼ 19/22) or endocarditis (n ¼ 3/22). Patients with aortic valve stenosis, MV stenosis, prior left-sided valve surgery, organic MV disease (prolapse, flail, cleft, and rheumatic disease), congenital heart disease, active endocarditis, LV assist device, or hypertrophic cardiomyopathy and those with insufficient image quality were not included. Clinical characteristics, medication use, and heart failure aetiology (ischaemic vs. non-ischaemic, including location of prior myocardial infarction) were retrieved from the departmental Cardiology Information System (EPD-Vision w , Leiden University Medical Center, Leiden, the Netherlands). Patients with FMR were divided into two groups according to the mitral regurgitation grade (FMR ,3 vs. ≥3). MV apparatus geometry and mitral leaflet remodelling were evaluated and compared between groups.
The institutional ethical committee approved this evaluation and waived the need for patient written informed consent for retrospective analysis of clinically collected data.
Two-dimensional echocardiography
All patients underwent two-dimensional (2D) transthoracic echocardiography in the left lateral decubitus position using commercially available ultrasound machines (Vivid-5, Vivid-7, and E9, GE-Vingmed, Milwaukee, WI, USA) equipped with 3.5 MHz and M5S transducers. 2D gray-scale and Doppler images were acquired in cine-loop format with ECGtriggering. Off-line analysis of these images was performed on a workstation (EchoPAC 112.0.0, GE Medical Systems, Horten, Norway). LV and left atrial dimensions were assessed as recommended. 9 LV end-diastolic and end-systolic diameters were measured at the parasternal long-axis view. The Simpson's biplane method was applied to quantify LV volumes and to calculate LV ejection fraction. Left atrial volume was also measured according to the biplane method. All volumes were indexed to body surface area. LV sphericity index was defined as the ratio of end-diastolic mid-ventricular width to the length of the LV.
Early (E) and late (A) diastolic mitral inflow velocities as well as deceleration time were assessed by pulsed-wave Doppler, placing the sample volume at the tips of the mitral leaflets. Septal mitral annulus velocities (E ′ ) were derived from tissue Doppler recordings and used to calculate the E/E ′ ratio. In line with current recommendations, integration of all available qualitative and (semi-)quantitative parameters assessed with 2D echocardiography, including vena contracta width and effective regurgitant orifice area (EROA) by the proximal isovelocity surface area method, were evaluated to grade FMR as trivial (1), mild (2), moderate (3), or severe (4). 10, 11 A vena contracta width between 3 -4, 5 -6, and ≥7 mm defined grade 2, 3, and 4 FMR, respectively. In addition, an EROA between 10.0 -14.9, 15.0 -19.9, and ≥20.0 mm 2 defined grade 2, 3, and 4 FMR, respectively.
3D echocardiography
Patients underwent 3D transoesophageal echocardiography using a Philips iE33 ultrasound machine (Philips Medical Systems). 3D datasets of the MV were acquired using full-volume or 3D zoom mode, comprising a pyramidal volume of 608 by 608. In order to maximize frame rate, multibeat (7 -14 beats) full-volume acquisitions were performed during breath-hold whenever possible or 1-beat 3D zoom acquisitions with the sector adjusted to include the MV if the patient could not hold the breath or when presenting with irregular heart rhythm such as atrial fibrillation.
3D MV quantification
3D volumetric datasets of the MV were studied off-line on a workstation (Qlab, Philips Medical Systems, version 9.0) using the dedicated commercially available MV Quantification (MVQ) software. To maximize spatial and temporal resolution, 3D full-volume acquisitions were preferred over 3D-zoomed acquisitions and mean frame rate was 26 frames/s.
Stepwise reconstruction of a 3D model of the MV was performed by a single experienced operator, blinded to FMR severity ( Figure 1A ). After selecting the end-systolic frame, multiplane reformation (MPR) planes were automatically displayed and manually aligned to obtain a bicommissural, outflow tract and short-axis view of the MV. In addition, a 3D volume rendering of the MV is displayed and can be additionally used for identification of anatomical landmarks. The short-axis plane was set at the level of the mitral annulus. The anterolateral and posteromedial part of the mitral annulus was then indicated on the bicommissural view, whereas the anterior and posterior mitral annulus points, as well as the mitral leaflet coaptation point and the aortic annulus, were set at the outflow tract view. An initial 3D model containing an annular ring and mitral leaflets was then automatically displayed. The mitral annulus on the 3D model was subsequently refined by indicating additionally eight pairs of annulus points on sequential MPR rotational cross-sections in the long-axis views, and the mitral leaflet commissural points were set on the short-axis MPR image. Subsequently, the mitral leaflets and the coaptation length were manually traced on multiple cross-sections (between 18 and 30) in the outflow tract view, orthogonal to the inter-commissural direction with a minimal distance of 0.17 cm between cross-sections. To correctly identify the coaptation point, the 3D-rendered volume of the MV (surgical en face view) was additionally used. Finally, the 3D model of the MV was displayed and several geometric measurements of the MV were automatically generated ( Figure 1B) . Lengths, areas, and volumes were indexed to body surface area. In particular, the antero-posterior and intercommissural annular diameter and circumferential annular area were assessed. In addition, the exposed leaflet area of the total MV and the respective anterior and posterior leaflets, representing the surface exposed to the left atrium, were derived. The overall leaflet area, including the exposed area and coaptation area of each mitral leaflet, was also Leaflet remodelling in functional mitral valve regurgitation computed. The coaptation area was calculated as the overall leaflet area minus the exposed leaflet area of the total MV. 8 Of note, the anatomical regurgitant orifice area is not excluded from the coaptation area as spatial resolution does not permit its adequate detection. The coaptation length at the central level (A2 -P2) and the tenting volume comprised between the leaflets and the annular surface area were also measured. Similar to prior reports, the ratio of overall total leaflet/annular area (leaflet/ annular area) and coaptation/overall total leaflet area (coaptation/leaflet area) were assessed as measures of leaflet remodelling, relative to the mitral annulus and LV changes.
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Statistical analysis
Continuous variables are presented as mean + SD and compared with the Student's t-test or Mann-Whitney U-test, as appropriate. Categorical variables are presented as number and percentages and compared by the Pearson x 2 test. Overall comparison among groups was performed by one-way analysis of variance (ANOVA) with Bonferroni post hoc testing (for continuous variables with normal distribution), KruskallWallis (for non-normally distributed continuous variables), or Pearson x 2 (for categorical variables) tests. Correlates of overall total mitral leaflet area were explored with linear regression analysis. In addition, binary logistic regression was performed to investigate the univariate associates of significant mitral leaflet remodelling (defined as ≥2 SD of the overall leaflet area of control subjects). A receiver operating characteristic (ROC) curve was subsequently constructed to evaluate the value of the coaptation/leaflet area to predict the presence of FMR ≥3. Uniand multivariate binary logistic regression analyses were in addition performed to identify independent correlates of FMR ≥3, using a backward elimination approach. Odds ratio (OR) and 95% confidence intervals (CIs) were obtained. A significance level of P , 0.10 qualified for entrance in the multivariate model. Finally, the association between the coaptation/leaflet area and the FMR grade was further explored by linear regression analysis. Intra-and inter-observer variability for overall and exposed MV leaflet area was evaluated by intraclass correlation for 15 randomly selected patients (5 control subjects, 5 FMR ,3, and 5 FMR ≥3 patients). Statistical analyses were performed using the SPSS software, version 20.0. (SPSS, Inc., Chicago, IL, USA). A two-sided P-value of ,0.05 was considered statistically significant.
Results Patients
Seventy-six patients were evaluated, including 22 controls (53 + 15 years old, 64% male), 24 patients with FMR ,3 (61 + 16 years old, 50% male), and 30 patients with FMR ≥3 (68 + 12 years old, 60% male). Characteristics of the control and FMR groups are outlined in Table 1 . Control subjects were younger, more likely to be in sinus rhythm, had less diabetes mellitus, and were using less cardiovascular medication. Patients with FMR ≥3 had lower systolic and diastolic blood pressure and higher prevalence of ischaemic heart failure aetiology, compared with those with FMR,3. Location of myocardial infarction between patients with ischaemic FMR ,3 vs. ≥3 was, however, similar. The use of cardiovascular medication was comparable between both groups. FMR patients had significantly larger LV diameters, LV volumes, LA volume and showed significantly worse LV systolic and diastolic function with higher systolic arterial pulmonary pressures compared with controls.
Mitral leaflet remodelling
Geometric and morphological characteristics of the mitral annulus and leaflets are listed in Table 2 . Patients with FMR had significantly larger annular diameters and area compared with controls. The (2), annulus diameters (3), total valve area (4), exposed valve area (5), and coaptation area (6), calculated as total minus exposed leaflet area, are assessed on the derived 3D model. A: anterior; AL: anterolateral; Ao: aorta; P: posterior; PM: posteromedial.
presence of leaflet remodelling was identified in both FMR groups showing larger overall leaflet area compared with controls. Patients with FMR ,3 and ≥3 had a respective relative increase in overall total leaflet area of 57 and 31%, respectively, compared with controls (both, P , 0.001). Significant leaflet remodelling, defined as ≥2 SD overall total leaflet area of control subjects, was respectively observed in 67% (n ¼ 16/24) and 37% (n ¼ 11/30) of patients with FMR ,3 and FMR ≥3. The pattern of relative leaflet remodelling was symmetrical for the anterior and posterior mitral leaflets. In patients with FMR ,3, the anterior and posterior mitral leaflet areas were increased by 53 and 62%, whereas in patients with FMR ≥3 these increments were of 31 and 32%, respectively. In addition, symmetrical leaflet remodelling was also noted in patients with infero-posterior myocardial infarction (n ¼ Leaflet remodelling in functional mitral valve regurgitation 39% relative increase in the posterior and anterior MV leaflet, respectively.
Correlates of mitral leaflet remodelling
Potential determinants of mitral leaflet remodelling were explored by logistic and linear regression analyses. Larger MV tenting volume (OR 10.04, 95% CI 3.52-28.68, P , 0.001), LV sphericity index ≥0.65 (OR 17.00, 95% CI 4.76 -60.77, P , 0.001), and increased mitral annulus area (OR 1.04, 95% CI 1.02-1.07, P , 0.001), all reflecting increased tethering forces, significantly correlated with the presence of significant leaflet remodelling and overall mitral leaflet area ( Figure 2 ). In addition, LV ejection fraction was significantly and inversely associated with the presence of significant leaflet remodelling (OR 0.94, 95% CI 0.91-0.97, P , 0.001) and overall MV leaflet area ( Figure 2 ).
Leaflet remodelling and mitral regurgitation severity
Significant mitral leaflet remodelling was present in both FMR groups. Importantly, a similar degree of tethering was noted in both groups, shown by comparable MV tenting volumes, annulus dilatation and LV size, shape and function ( Tables 1 and 2 ). Less extensive leaflet remodelling, however, was observed in patients with FMR ≥3 vs. ,3, as reflected by smaller overall total MV leaflet area ( Table 2 and Figure 3) . This difference was mainly attributed to smaller coaptation area in patients with FMR ≥3 compared with those with FMR ,3, as both groups had comparable exposed leaflet area. The coaptation/leaflet area was preserved (proportional to increased leaflet size) in patients with FMR ,3; however, it was significantly decreased in patients with FMR ≥3 compared with control patients, reflecting insufficient leaflet remodelling (lack of coaptation reserve) to compensate for the requirements of the dysfunctional dilated LV (Figure 4) . The ROC curve analysis showed that coaptation/ leaflet area was an accurate predictor of the presence of FMR ≥3 with area under the curve (AUC) ¼ 0.925 (P , 0.001; Figure 5A ). In particular, a coaptation/leaflet area of ≤0.24, indicating a coaptation area of ≤24% of the overall total leaflet area, had a sensitivity and specificity of 90 and 91% to predict the presence of FMR ≥3, respectively. As provided in Table 3 , the multivariate regression analysis demonstrated that coaptation/leaflet area of ≤0.24 is strongly related to the presence of FMR ≥3, independently of the degree of LV tethering or infarct location in case of ischaemic FMR. The coaptation/leaflet area showed a significant inverse correlation with FMR severity (r 2 ¼ 0.38, P , 0.001; Figure 5B ). Additionally, the leaflet/annular area ratio of patients with FMR ≥3 was significantly smaller than those with FMR ,3, suggesting insufficient leaflet remodelling to compensate for the increased annulus size.
Reproducibility
Intraclass correlation coefficients for overall (total) leaflet area were 0.903 (intra-observer) and 0.947 (inter-observer). For exposed leaflet area measurements, the intraclass correlation coefficients were 0.955 and 0.947 for intra-observer and inter-observer reproducibility, respectively. 
Discussion
The present evaluation demonstrated that MV leaflet remodelling is common in FMR, showing a symmetrical involvement of both leaflets, and relates to MV tethering and closing forces. In addition, insufficient MV leaflet remodelling to compensate for annular and LV changes is strongly and independently associated with FMR severity, reflecting a potential therapeutic target for patients with functional MV disease.
Leaflet remodelling evidence
FMR results from an imbalance between valvular closing (LV dysfunction, LV and papillary muscle dyssynchrony and reduced annular contraction) and tethering forces (LV sphericity, papillary muscle displacement, annular dilatation, and MV tenting). 2, 12 This imbalance causes relocation of the MV coaptation point more apically and/or posteriorly, thereby restricting the leaflets movement with secondary loss of coaptation and FMR. 12 Therefore, FMR is generally regarded as a ventricular problem leading to dysfunction of a structurally normal valve. 2 Differences in FMR severity despite similar tethering degree, however, have been observed. 6 -8 For instance, in patients with moderate to severe aortic regurgitation and significant LV remodelling, the prevalence of FMR is surprisingly low. 6 Such observations enforce the idea that the MV itself might develop compensatory adaptations to the chronic stress imposed by the annular and LV changes. 7, 13 Indeed, alterations in biochemical extracellular matrix and increased cellularity in mitral leaflets of humans with LV dysfunction have been reported. 3 This ultra-structural remodelling FMR show larger total mitral leaflet area than control subjects (leaflet remodelling). Leaflet area in patients with FMR ≥3 vs. ,3, however, is smaller, mainly due to smaller coaptation area rather than exposed leaflet area. Insufficient leaflet remodelling resulting in the lack of coaptation reserve might prohibit adequate systolic leaflet closure and facilitate occurrence of significant FMR. FMR: functional mitral regurgitation; MV: mitral valve.
Leaflet remodelling in functional mitral valve regurgitation coincides with increased stiffness and reduced leaflet stretch abilities. 14 In addition, structural mitral leaflet remodelling, including increased mitral leaflet length, area, and thickness in response to mitral annular and LV dilatation, was observed in animal models of both ischaemic and non-ischaemic heart failure. 5, 13, 15 Evidence of prospective increase in mitral leaflet size .30% in response to imposed stress and as the result of an active biological process was recently provided by longitudinal animal model studies. 5, 15 The current evaluation also shows that patients with FMR have an increased MV area of .30% compared with normal controls, indicating the presence of leaflet remodelling. These findings are in line with previous reports on transthoracic or transoesophageal 3D echocardiography of the MV, showing relative increases in mitral leaflet area of 23 -35%. 6 -8 This evidence suggests that, in patients with FMR, the MV shows structural remodelling and should, therefore, not be regarded as 'normal'.
Characteristics and determinants of leaflet remodelling
The present evaluation indicates that significant leaflet remodelling (defined as ≥2 SD of the overall leaflet area of control subjects) is prevalent. In addition, a symmetrical pattern of relative enlargement of the posterior compared with the anterior MV leaflet was found, even in patients with ischaemic cardiomyopathy with prior inferoposterior myocardial infarction. These findings are in line with a recent finite element analysis in a unique sheep model of the LV and MV after infero-posterior infarction, showing that both anterior and posterior MV leaflets were subjected to similar extent of leaflet stress. 16 As the posterior and anterior MV leaflets have comparable surface areas, one could anticipate that the leaflets show similar extent of enlargement, as shown in the current study. 17 Another study using an animal model of non-ischaemic cardiomyopathy also reported a similar relative increase in the anterior and posterior mitral leaflet area. 13 Other factors than leaflet stress alone, however, might also determine leaflet remodelling. In a recent sheep model with a perforation created in the anterior mitral leaflet, ultra-structural leaflet remodelling at follow-up was identified, suggesting that isolated MR is able to cause leaflet remodelling of the MV. 18 However, data on determinants of structural leaflet remodelling in humans are limited. Our findings suggest that both tethering (LV sphericity, annulus size, and tenting volume) and closing forces (LV systolic function) are potential determinants of leaflet remodelling. A preserved or higher leaflet/annular ratio in FMR patients compared with controls confirms the idea that leaflet size increases relative to annular dilatation. Other reports have shown similar findings. 6 -8 These results indicate that leaflet remodelling occurs as an adaptive response to annular and LV changes that pose specific requirements to the mitral leaflet size to ensure adequate surface and leaflet coaptation area to prevent from significant FMR.
Leaflet remodelling and regurgitation severity
Despite similar tethering and LV remodelling degree, patients with FMR ≥3 compared with ,3 intriguingly showed a less increase in MV area. These results point out that isolated LV remodelling fails to account for the observed FMR variability. The reported variability of FMR prevalence in ischaemic patients may suggest that there are other associated pathophysiological factors than regional or global LV remodelling or dysfunction contributing to FMR. 19, 20 In the present study, although ischaemic aetiology was significantly more frequent among FMR ≥3 patients than in FMR ,3 patients, the location of myocardial infarction was not significantly different within the FMR ≥3 group. In addition, there was significant leaflet remodelling difference between groups that was attributed mainly to smaller coaptation area rather than exposed leaflet area. Hence, coaptation/ leaflet area (coaptation index) was significantly smaller in FMR ≥3 patients vs. FMR ,3 patients, similar to a prior report on 3D transoesophageal echocardiography and comparable to two other studies that mentioned smaller leaflet/exposed (closure) area. These data suggest that leaflet remodelling in FMR ≥3 patients is insufficient to compensate for the changes in MV annular and LV dimensions. In particular, the lack of coaptation reserve defined by the ratio of coaptation/leaflet area was an independent associate of significant FMR. The presence of limited coaptation reserve ,24% of total MV area was independently related to FMR severity. These findings are in line with the study by Chaput et al. 7 reporting a cut-off value for the leaflet/closure area ratio of ,1.7 to predict the presence of significant FMR, which reflects ,30% coaptation reserve. This absolute difference in cut-off value compared with our study might be due to the measurement of MV area at a different time point during the cardiac cycle, to the use of different 3D quantification software, and to the use of transthoracic 3D echocardiography characterized by lower spatial resolution, compared with transoesophageal 3D echocardiography. 21 
Clinical significance
The current data show, in line with previous reports, that the presence of larger MV leaflets for the same LV tethering degree may protect from FMR. 6 -8 These findings might have implications for the treatment of FMR patients, which remains a clinical challenge. 2 First, elucidating the mechanisms including signalling pathways and triggers that are responsible for leaflet remodelling may help to explain the variability in leaflet remodelling observed in patients despite similar LV dilatation. This knowledge might lead to identification of patients with LV dysfunction that are prone to inadequate MV leaflet remodelling. These patients would represent ideal candidates to undergo biological modification with specific drugs developed to block adverse or stimulate beneficial remodelling of mitral leaflets to prevent from significant FMR.
Secondly, results of restrictive mitral annuloplasty for FMR overall have been relatively disappointing with high recurrence rates at medium to long-term follow-up. In addition, no robust survival benefit has been shown so far for FMR surgery. 2 Current data lend support to the principle of surgical mitral leaflet augmentation plasty, which involves insertion of a pericardial bovine patch into the anterior or posterior MV leaflet in addition to restrictive annuloplasty. 22, 23 MV augmentation plasty increases MV leaflet area, reduces leaflet stress, and increases coaptation reserve which might be of paramount importance as the underlying process of adverse LV remodelling potentially continues, imposing specific requirements to the MV area. 22, 24 Given the importance of coaptation reserve that should ideally exceed 24% of the total MV area, as indicated by the current study, this alternative surgical MV repair technique might warrant further study. Small series using posterior (n ¼ 44) and anterior (n ¼ 25) leaflet augmentation have shown promising results, but long-term results are lacking. 22, 23 The complexity of LV remodelling and FMR, however, probably precludes a single best option to treat FMR that rather requires a tailored approach to the individual patient and MV complex.
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Limitations FMR severity assessment is prone to well-known limitations and challenges associated with the functional nature of the valvular regurgitation. The use of a multi-integrative approach, as recommended, partly accounts for these limitations. Mitral leaflet area was assessed at endsystole to ensure the evaluation of leaflet coaptation. Therefore, a contribution of acute stretch to the measured leaflet area, known to potentially increase leaflet size, cannot be excluded. 26 Similar values for leaflet areas compared with our study measured during diastole, however, have been reported. 6, 7 In addition, leaflet remodelling in FMR occurs also independently of acute leaflet stretching. 5 Furthermore, LV volumes were derived from 2D echocardiographic data. Due to retrospective analysis in a limited number of patients, the present study should be interpreted as hypothesis generating analysis.
Conclusion
Mitral leaflet remodelling in patients with FMR is highly prevalent, symmetrical and determined by MV closing and tethering forces. Insufficient leaflet remodelling relative to the annular and LV dilatation causes lack of coaptation reserve and is independently associated with FMR severity. MV leaflets in FMR should not be regarded as 'normal' and might represent a biological or interventional therapeutic target.
